CAH - Cardinal Health, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Marvan, Jan 14, 2022 at 3:57 AM.

  1. Marvan

    Marvan Active Member

    Joined:
    Mar 16, 2019
    Messages:
    919
    Likes Received:
    94
    Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.

    It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

    The company operates in two segments, Pharmaceutical and Medical.

    The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.

    The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals.

    The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.

    The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.

    It has a collaboration agreement with Journey Biosciences, Inc.

    Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
     
  2. Marvan

    Marvan Active Member

    Joined:
    Mar 16, 2019
    Messages:
    919
    Likes Received:
    94
  3. Marvan

    Marvan Active Member

    Joined:
    Mar 16, 2019
    Messages:
    919
    Likes Received:
    94
    Bear of the Day: Cardinal Health (CAH)

    Sometimes, it is easy to get caught up in the momentum of a fast-moving stock. We have all heard the old adage of “Buy low and sell high” but it is equally as fun to “Buy high and sell higher.” You have to be sure that your stock that is on the move has staying power and is not just on a quick sugar high. One way to figure this out is by looking at earnings. Stocks with the strongest earnings trends tend to outperform those with weak earnings profiles. When analysts on Wall Street start moving their numbers in the wrong direction, it can lead to problems for a stock’s price.

    Today’s Bear of the Day is a stock that has seen earnings estimate revisions coming down. That stock is Cardinal Health CAH. Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical.

    Currently, Cardinal Heath is a Zacks Rank #5 (Strong Sell). The reason for the unfavorable Zacks Rank is the recent earnings estimate revisions from analysts all over Wall Street. Over the last sixty days, two analysts have cut their expectations for both the current year and next year. The bearish sentiment has dropped our Zacks Consensus Estimates for the current year from $5.85 to $5.60 while next year’s number is off from $6.57 to $6.14. That current year number represents a mere 54 bps of growth over last year while next year is forecast to come in at 9.6% growth. Sales growth has still been relatively strong with 9.15% this year and 4.81% next year.

    https://uk.finance.yahoo.com/news/bear-day-cardinal-health-cah-120012122.html


    Cardinal Health, Inc. (CAH)
    NYSE - NYSE Delayed price. Currency in USD
    In watchlist
    53.09+0.85 (+1.63%)
    At close: 14 January 04:00PM EST
    53.26 +0.17 (+0.32%)
    After hours: 07:21PM EST
     

Share This Page